Karydas Daphne - Insider Non-Derivative Transactions at Mineralys Therapeutics, Inc. (MLYS) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Nov 13, 2025, Karydas Daphne's relationship to Mineralys Therapeutics, Inc. (MLYS) is Director, and currently has 15,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MLYS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Karydas Daphne - Insider Non-Derivative Transactions of MLYS Common Stock

Karydas Daphne - Insider Non-Derivative Transactions at MLYS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 14, 2025	Sell -- (Common Stock)	4885	46.36	0
Nov 14, 2025	Sell -- (Common Stock)	10115	45.81	4885
Nov 14, 2025	M -- (Common Stock)	15000	10.2	15000